Variants in the insulin-degrading enzyme gene are associated with metabolic syndrome in Chinese elders

Metabolism: Clinical and Experimental

Volumn 58, Issue 10, 2009, Pages 1465-1469

  Lu, Xiaozhe ^a   Huang, Yanyan ^a   Liu, Yun ^b   Wu, Xiaoyan ^a   Shi, Xiaomei ^a  

^a FUDAN UNIVERSITY   (China)

^b Chinese Academy of Sciences   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INSULINASE;

AGED; ALLELE; ARTICLE; CASE CONTROL STUDY; CHINA; CHINESE; CONTROLLED STUDY; FEMALE; GENE; GENE FUNCTION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; INSULINASE GENE; MAJOR CLINICAL STUDY; MALE; MARKER GENE; METABOLIC SYNDROME X; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; AGED, 80 AND OVER; ALLELES; ANTHROPOMETRY; BLOOD CHEMICAL ANALYSIS; CHINA; DNA PRIMERS; FEMALE; GENE FREQUENCY; GENOTYPE; HAPLOTYPES; HUMANS; INSULYSIN; INTRONS; MALE; METABOLIC SYNDROME X; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 70149100414     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2009.04.027     Document Type: Article

References (32)

1. Martínez M.A., Puig J.G., Mora M., Araqón R., O'Doqherty P., Antón J.L., et al. Metabolic syndrome: prevalence, associated factors and C-reactive protein: the MADRIC (Madrid Rlesgo Cardiovascular) Study. Metabolism 57 (2008) 1232-1240
2. Buckland G., Salas-Salvadó J., Roure E., Bulló M., and Serra-Majem L. Sociodemographic risk factors associated with metabolic syndrome in a Mediterranean population. Public Health Nutr 5 (2008) 1-7
3. Yamada Y., Ichihara S., Kato K., Yoshida T., Yokoi K., Matsuo H., et al. Genetic risk for metabolic syndrome: examination of candidate gene polymorphisms related to lipid metabolism in Japanese people. J Med Genet 45 (2008) 22-28
4. Kilpeläinen T.O., Lakka T.A., Laaksonen D.E., Maqer U., Salopuro T., Kubaszek A., et al. Interaction of single nucleotide polymorphisms in ADRB2, ADRB3, TNF, IL6, IGF1R, LIPC, LEPR, and GHRL with physical activity on the risk of type 2 diabetes mellitus and changes in characteristics of the metabolic syndrome: the Finish Diabetes Prevention Study. Metab Clin and Exper 57 (2008) 428-436
5. Kisfali P., Mohás M., Maasz A., Hadarits F., Markó L., Horvatovich K., et al. Apolipoprotein A5 IVS3+476A allelic variant associates with increased triglyceride levels and confers risk for development of metabolic syndrome in Hungarians. Circ J 72 (2008) 40-43
6. Love-Gregory L., Sherva R., Sun L., Wasson J., Schappe T., Doria A., et al. Variants in the CD36 gene associate with the metabolic syndrome and high-density lipoprotein cholesterol. Hum Mol Genet 17 (2008) 1695-1704
7. Wiedmann S., Fischer M., Koehler M., Neureuther K., Rieqqer G., Doerinq A., et al. Genetic variants within the LPIN1 gene, encoding lipin, are influencing phenotypes of the metabolic syndrome in humans. Diabetes 57 (2008) 209-217
8. Vaxillaire M., Veslot J., Dina C., Proenca C., Cauchi S., Charpentier G., et al. Impact of common type 2 diabetes risk polymorphisms in the DESIR prospective study. Diabetes 57 (2008) 244-254
9. Procopious M., and Philippe J. The metabolic syndrome and type 2 diabetes: epidemiological figures and country specificities. Cerebrovasc Dis 20 (2005) 2-8
10. Gu H.F., Efendic S., Nordman S., Ostenson C.G., Brismar K., Brookes A.J., et al. Quantitative trait loci near the insulin-degrading enzyme (IDE) gene contribute to variation in plasma insulin levels. Diabetes 53 (2004) 2137-2142
11. Florez J.C., Wiltshire S., and Agapakis C.M. High-density haplotype structure and association testing of the insulin degrading enzyme (IDE) gene with type 2 diabetes in 4206 people. Diabetes 55 (2006) 128-135
12. Kwak S.H., Cho Y.M., Moon M.K., Kim J.H., Park B.L., Cheonq H.S., et al. Association of polymorphisms in the insulin-degrading enzyme gene with type 2 diabetes in the Korean population. Diabetes Res Clin Pract 79 (2008) 284-290
13. Karamohamed S., Demissie S., and Volcjak J. Polymorphisms in the insulin-degrading enzyme gene are associated with type 2 diabetes in men from the NHLBI Framingham Heart Study. Diabetes 52 (2003) 1562-1567
14. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285 (2001) 2508-2509
15. Sham P.C., and Curtis D. Monte-Carlo tests for associations between disease and alleles at highly polymorphic loci. Ann Hum Genet 59 (1995) 97-105
16. Zapata C., Carollo C., and Rodriguez S. Sampling variance and distribution of the D' measure of overall gametic disequilibrium between multiallelic loci. Ann Hum Genet 65 (2001) 201-203
17. Xie X., and Ott J. Testing linkage disequilibrium between a disease gene and marker loci, in: the American Society of Human Genetics annual meeting 1993. Am J Hum Genet 65 Suppl 53 (1993) 1107
18. Zhao J.H., Curtis D., and Sham P.C. Model-free analysis and permutation tests for allelic associations. Hum Hered 50 (2000) 133-139
19. Erdfelder E., Faul F., and Buchner A. G*Power: a general power analysis program. Behav Res Methods Instrum Comput 28 (1996) 1-11
20. Wiltshire S., Hattersley A.T., Hitman G.A., Walker M., Levy J.C., Sampson M., et al. A genomewide scan for loci predisposing to type 2 diabetes in a UK population (the Diabetes UK Warren 2 Repository): analysis of 573 pedigrees provides independent replication of a susceptibility locus on chromosome 1q. Am J Hum Genet 69 (2001) 553-569
21. Meigs J.B., Panhuysen C.I.M., Myers R.H., Wilson P.W.F., and Cupples L.A. A genome-wide scan for loci linked to plasma levels of glucose and HbA1c in a community-based sample of Caucasian pedigrees: the Framingham Offspring Study. Diabetes 51 (2002) 833-840
22. Farris W., Mansourian S., Leissring M.A., Eckman E.A., Bertram L., Eckman C.B., et al. Partial loss-of-function mutations in insulin-degrading enzyme that induce diabetes also impair degradation of amyloid beta-protein. Am J Pathol 164 (2004) 1425-1434
23. Fasquier F., Boulogne A., Leys D., and Fontaine P. Diabetes mellitus and dementia. Diabetes Metb 32 (2006) 403-414
24. Reich D.E., and Lander E.S. On the allelic spectrum of human disease. Trends Genet 17 (2001) 502-510
25. Smith D.J., and Lusis A.J. The allelic structure of common disease. Hum Mol Genet 11 (2002) 2455-2461
26. Hamel F.G., Upward J.L., and Bennett R.G. In vitro inhibition of insulin-degrading enzyme by long-chain fatty acids and their coenzyme A thioesters. Endocrinology 144 (2003) 2404-2408
27. Neant-Fery M., Garcia-Ordonez R.D., Logan T.P., Selkoe D.J., Li L., Reinstatler L., et al. Molecular basis for the thiol sensitivity of insulin-degrading enzyme. Proc Natl Acad Sci U S A 105 (2008) 9582-9587
28. Shinall H., Song E.S., and Hersh L.B. Susceptibility of amyloid beta peptide degrading enzymes to oxidative damage: a potential Alzheimer's disease spiral. Biochemistry 44 (2005) 15345-15350
29. Im H., Manolopoulou M., Malito E., Shen Y., Zhao J., Neant-Fery M., et al. Structure of substrate-free human insulin-degrading enzyme (IDE) and biophysical analysis of ATP-induced conformational switch of IDE. J Bio Chem 282 (2007) 25453-25456
30. Groves C.J., Wiltshire S., Smedley D., Owen K.R., Frayling T.M., Walker M., et al. Association and haplotype analysis of the insulin-degrading enzyme (IDE) gene, a strong positional and biological candidate for type 2 diabetes susceptibility. Diabetes 52 (2003) 1300-1305
31. Lohmueller K., Pearce C.L., Pike M., Lander E.S., and Hirschhorn J.N. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet 33 (2003) 177-182
32. Park Y.W., Zhu S., Palaniappan S., Heshko S., Carnethon M.R., and Heymsfield S.B. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 163 (2003) 427-436